Literature DB >> 19143575

Neutral and acidic hydrolysis reactions of the third generation anticancer drug oxaliplatin.

Maria Fatima A Lucas1, Mateij Pavelka, Marta E Alberto, Nino Russo.   

Abstract

The hydrolysis of oxaliplatin, a third generation anticancer drug, is expected to play an important role in the activation of this compound before it reaches DNA. The first and second hydrolysis corresponding to the addition of the first water molecule concomitant with the ring-opening, followed by addition of a second water and loss of the monodentate oxalato ligand, respectively, were studied combining density functional theory (DFT) with the conductor-like dielectric continuum model (CPCM) approach. The reaction was studied in neutral and acidic conditions, and all stationary points have been identified. The computed potential energy surfaces show that, for the neutral hydrolysis, the ring-opening reaction is the rate-limiting process, with an activation barrier of about 28 kcal/mol. For the acid degradation in water, according to experimental data, the reaction is expected to proceed in a faster biphasic process, and the rate-limiting process is the ligand detachment that occurs with a barriers of about 22 kcal/mol. According to the calculated results, we expect that the reaction is favored in acidic conditions and that the monoaquated complex should be the species reacting with DNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19143575     DOI: 10.1021/jp8086539

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  6 in total

1.  Atomic level rendering of DNA-drug encounter.

Authors:  Maria F Lucas; Israel Cabeza de Vaca; Ryoji Takahashi; Jaime Rubio-Martínez; Víctor Guallar
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

2.  Activation of the cisplatin and transplatin complexes in solution with constant pH and concentration of chloride anions; quantum chemical study.

Authors:  Tomáš Zimmermann; Jerzy Leszczynski; Jaroslav V Burda
Journal:  J Mol Model       Date:  2011-04-27       Impact factor: 1.810

3.  Iodide Analogs of Arsenoplatins-Potential Drug Candidates for Triple Negative Breast Cancers.

Authors:  Ðenana Miodragović; Wenan Qiang; Zohra Sattar Waxali; Željko Vitnik; Vesna Vitnik; Yi Yang; Annie Farrell; Matthew Martin; Justin Ren; Thomas V O'Halloran
Journal:  Molecules       Date:  2021-09-06       Impact factor: 4.927

4.  Synthesis, Characterization, Thermal Analysis, DFT, and Cytotoxicity of Palladium Complexes with Nitrogen-Donor Ligands.

Authors:  Sattar R Majeed; Mina A Amin; Fawzy A Attaby; Marta E Alberto; Ahmed A Soliman
Journal:  Molecules       Date:  2022-01-31       Impact factor: 4.411

5.  Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.

Authors:  Rudra Pangeni; Sang Won Choi; Ok-Cheol Jeon; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2016-11-30

6.  The hybrid models, containing hydrolytic and electron-driven processes, in theoretical study of oxaliplatin biotransformation.

Authors:  Janina Kuduk-Jaworska; Jerzy J Jański; Szczepan Roszak
Journal:  J Mol Model       Date:  2020-09-26       Impact factor: 1.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.